FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market
The U.S. Food and Drug Administration has approved Eli Lilly‘s GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight loss medications. Lilly said the once-daily pill, Foundayo, will start shipping from direct-to-consumer […]
Health
.png?width=1200&height=800&crop=1200:800&w=650&resize=650,434&ssl=1 "Poll: Are age-gap relationships always wrong?")
